Sidra Medicine
Sidra Medicine is a JCI-accredited academic medical center and Qatar Foundation member in Doha, providing specialized clinical care, research, and medical education for women, children, and young people across Qatar and the MENA region.
- Company typePrivate
- Founded2016
- HeadquartersDoha, Qatar
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Sidra Medicine does
Sidra Medicine is a private, non-profit academic medical center and member of Qatar Foundation, headquartered in Doha, Qatar, specializing in healthcare for women, children, and young people. Founded in 2016 and JCI Gold Seal-accredited, the institution operates a single full-service hospital campus with outpatient clinics, inpatient care, an emergency department, and specialty services spanning reproductive medicine/IVF, obstetrics, gynecology, menopause, pediatric orthopedics, child and adolescent mental health, developmental pediatrics, and rehabilitation medicine. Its core technology stack integrates a PacBio-certified Central Genomics Unit participating in the Hi-Fi Solves Alliance, a Pediatric Biobank, a CE-marked/FDA-cleared AI-powered X-ray interpretation tool deployed in the Pediatric Emergency Department, and a GMP-compliant manufacturing facility producing autologous serum eye drops and a G-Rex-based CAR-T cell therapy platform for pediatric oncology, supplemented by a Microbiome Service and a Laboratory of Reproductive Biology. Revenue is generated across patient-care services (billed through six insurance partners plus self-pay), medical education programs (Medical Observership Programme, Future Doctor Programme), research grants (e.g., ScaleReady's $100,000 G-Rex Grant), and emerging commercial biologics and microbiome services distributed to academic and industry investigators across the MENA region. The hospital additionally runs international medical convoys, hosts regional conferences (QAPEX 2025, MENA Microbiome Conference 2026), and pursues corporate healthcare partnerships such as the QatarEnergy MoU.
Sidra Medicine firmographics
Firmographics- Name
- Sidra Medicine
- Legal name
- Sidra Medicine
- Website
- https://sidra.org
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Sidra Medicine is a JCI-accredited academic medical center and Qatar Foundation member in Doha, providing specialized clinical care, research, and medical education for women, children, and young people across Qatar and the MENA region.
- Ownership category
- akta.pro rank
Sidra Medicine industry classification
Industry- Product category
- Academic Medical Center / Specialty Pediatric and Women's Healthcare
- NAICS
- General Medical and Surgical Hospitals (622110), Offices of Physicians (6211), Health Care and Social Assistance (62)
- SIC
- Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Pediatrics & Adolescent Medicine Practices (HLAFAJAF)
Keywords
Where Sidra Medicine is headquartered
LocationHeadquarters
- HQ city
- Doha
- HQ country
- Qatar
- HQ region
- Middle East
Offices1 record
Markets served
Sidra Medicine business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Patient Care Services: Revenue generated from hospital services including outpatient clinics, inpatient care, surgical procedures, diagnostic services, and specialized treatments for women, children, and young people. Services include IVF, maternity care, pediatric services, and emergency care.
- Insurance Billing: Direct billing agreements with insurance companies including QLM, Al-Koot, MSH International, GlobeMed, AP Companies, and LGA Assistance. Also accepts self-paying patients.
- Medical Education Programs: Revenue from educational programs including the Medical Observership Programme for healthcare professionals and Future Doctor Programme for secondary school students. Certifications accredited by the American Heart Association.
- Research Grants and Partnerships: External funding through grants such as the $100,000 G-Rex Grant from ScaleReady and collaborative partnerships with organizations like Builders VC MENA for healthcare innovation development.
- Microbiome Service: Private-paid specialized microbiome testing and analysis service for academic and industry investigators in the MENA region who lack infrastructure to process their samples.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Insurance-covered services |
| Other | Pay-as-you-go | Self-pay patients |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Sidra Medicine product offering
Product offeringCore offering
Sidra Medicine provides specialized clinical care for women, children, and young people through three service divisions: Children & Young People's Services (pediatric orthopedics, mental health, rehabilitation, autism services, obesity care), Women's Services (reproductive medicine and IVF, obstetrics, gynecology, menopause), and Adult Services. The institution complements direct patient care with research programs (precision medicine, genomics, Pediatric Biobank, microbiome analysis, CAR-T cell therapy development) and medical education offerings including observerships and fellowships.
Product overview
Sidra Medicine is a JCI-accredited academic medical center and member of Qatar Foundation, providing specialized healthcare services for women, children, and young people in Qatar. The institution operates as a unified hospital offering clinical services organized into three main divisions: Children & Young People's Services (including pediatric orthopedics, mental health, rehabilitation, and specialty programs), Women's Services (including reproductive medicine/IVF, obstetrics, gynecology, and menopause care), and Adult Services. Sidra Medicine's product portfolio includes core clinical services like pediatric obesity care and autism support programs, specialized therapeutic offerings such as the Pediatric Orthopedic Sports Medicine service with growth-sparing techniques, CAMHS mental health services, and Pediatric Rehabilitation Medicine. The organization has launched innovative programs including an AI-powered X-ray interpretation tool for pediatric emergency care, a Microbiome Service for precision medicine, and Qatar's first autologous serum eye drops from its GMP facility. Advanced therapies include the G-Rex CAR-T cell therapy platform for pediatric oncology, sacral neuromodulation for bladder dysfunction, and interventional radiology procedures. Research infrastructure includes a Pediatric Biobank and Precision Medicine Program. Educational offerings include the 'Teach Me How' autism parent program and Future Doctor Program for secondary school students.
Differentiator
Problem solved
Functional benefit
Products and services
- Pediatric Obesity Care Program Comprehensive treatment programs for childhood obesity delivered through a multidisciplinary care model involving pediatricians, endocrinologists, dietitians, psychologists, and other specialists. Includes Qatar's first comprehensive adolescent eating disorders clinic launched in 2025.
- Reproductive Medicine and In Vitro Fertilization (IVF) World-class IVF and fertility services offering conventional IVF, ICSI, PGT, ovulation induction, IUI, and fertility preservation including egg, embryo, and sperm cryopreservation. Uses Matcher electronic witnessing system and Embryoscope time-lapse imaging for embryo selection.
- Pediatric Orthopedic Sports Medicine Specialized pediatric orthopedic sports medicine service delivering growth-sparing surgical techniques for children and young adults with sports-related injuries, including minimally invasive arthroscopic techniques with all-suture anchors that preserve growth plates.
- Child and Adolescent Mental Health Services (CAMHS) Comprehensive mental health services for children and adolescents aged 5 to 18, providing assessment and treatment for autism spectrum disorder, ADHD, anxiety disorders, mood disorders, OCD, and other conditions. Includes outpatient clinic, psychotherapy, medication management, and psychological assessments.
- Microbiome Service Specialized microbiome testing and analysis service supporting precision medicine, clinical research, and personalized healthcare for women, children, and young people. Combines cutting-edge sequencing technologies with multidisciplinary research expertise for academic and industry investigators in the MENA region.
- Autologous Serum Eye Drops Qatar's first autologous serum eye drops - a personalized biologic treatment for severe dry eye conditions. Marks Sidra Medicine's first commercial biologic from the GMP facility, enabling locally produced, high-quality, individualized therapies.
- Pediatric Rehabilitation Medicine Comprehensive rehabilitation services for children with physical disabilities, chronic conditions, or those recovering from serious illness or injury. Includes General Rehabilitation Clinic, Spina Bifida MDT Clinic, and Movement Disorders MDT Clinic offering advanced interventions such as selective dorsal rhizotomy and intrathecal baclofen pump therapy.
- Sacral Neuromodulation Minimally invasive sacral neuromodulation implantation procedure for children with severe bladder dysfunction, including spina bifida patients. Qatar's first pediatric sacral neuromodulation procedure was performed at Sidra Medicine in February 2026.
- AI-Powered X-ray Interpretation Tool AI-powered X-ray interpretation tool integrated into the Pediatric Emergency Department for faster diagnosis and reduced waiting times. CE-marked and FDA-cleared technology that prioritizes potentially urgent cases and improves collaboration between emergency physicians and radiologists.
- Precision Nutrition Research Research programs studying how maternal nutrition affects fetal development through epigenetic changes, including studies linking protein/vitamin/mineral intake to birth outcomes and gestational diabetes associations with dietary fat consumption.
- G-Rex CAR-T Cell Therapy Platform G-Rex centric CAR-T cell therapy platform for pediatric oncology, developed with a $100,000 G-Rex Grant from ScaleReady. Supports creation of a GMP-compliant production system for scalable and cost-effective CAR-T therapy manufacturing.
- Autism Support Services Comprehensive autism care including diagnostic services, the BARAKA genomic study, and the 'Teach Me How' parent empowerment program. Diagnostic wait times reduced from nine to six months under QF Autism Strategy.
- Gynecology Services Comprehensive gynecology care for women of all ages including pediatric and adolescent gynecology, cervical screening and prevention, menopause clinic, and advanced minimally invasive surgeries including robotic and laparoscopic procedures.
- Pediatric Biobank Pediatric biobank storing and documenting biological samples including tissue, blood, urine, saliva, and stool samples to enable scientists to access samples and information for population-specific medical research.
- Precision Medicine Program Personalized healthcare approach considering a patient's genes, environment, and lifestyle to provide tailored care, including genomic diagnosis, early intervention for genetic conditions, and access to innovative treatments.
- Interventional Radiology Services Minimally invasive interventional radiology procedures including endovascular embolization for AVM treatment, utilizing catheter-based techniques through small incisions for targeted therapy with quick recovery times.
- Teach Me How Program Comprehensive educational program on Autism Spectrum Disorder (ASD) designed to empower parents and caregivers with knowledge and skills to support their neurodiverse children through interactive sessions with developmental pediatrics experts.
Quantifiable outcome
- Reduced diagnostic wait times from nine to six months for autism
- +3 more outcomes
Companies that use Sidra Medicine
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles4 records
Sidra Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
Sidra Medicine partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- World Innovation Summit for Health (WISH)minorWISH is an initiative under Qatar Foundation convening global healthcare leaders. Sidra Medicine participates in the summit focusing on themes including AI in human-centred health, with Dr. Sunoor Verma highlighting gaps between scientific innovation and patient access.
- Dr. Tariq Al-Shaiji (Consultant Urologist, Kuwait)minorCollaborated with Dr. Tariq Al-Shaiji from Kuwait for Qatar's first pediatric sacral neuromodulation procedure. Dr. Al-Shaiji brought extensive experience in sacral neuromodulation to support the introduction of this procedure at Sidra Medicine for children with bladder dysfunction.
- QatarEnergycoreSidra Medicine and QatarEnergy signed a Memorandum of Understanding to establish a framework for collaboration in healthcare services, professional development, and expertise exchange. The agreement covers commercial healthcare solutions including insurance pathways and tailored maternity and corporate healthcare packages, as well as continuing medical education and clinical service coordination for QatarEnergy employees. The partnership aims to strengthen Qatar's healthcare ecosystem.
- Builders VC MENAcoreSidra Medicine signed a memorandum of understanding with Builders VC MENA to strengthen collaboration in healthcare innovation and support the development of medical technologies through public-private partnerships. The agreement combines Builders VC's investment expertise and portfolio network with Sidra Medicine's research-driven ecosystem and clinical infrastructure to advance biotech and health-tech solutions. The partnership aims to create tangible healthcare innovations benefiting Qatar and beyond.
- Hi-Fi Solves AlliancecoreSidra Medicine joined the Hi-Fi Solves Alliance, a global consortium advancing long-read genomic sequencing technologies to improve rare disease diagnosis. As part of this, Sidra Medicine's Central Genomics Unit became a PacBio-certified service provider, reinforcing Qatar's position as a regional hub for AI-driven genomic medicine and precision healthcare innovation.
- Qatari Business Women's Association (QBWA)minorSidra Medicine and the Qatari Business Women's Association signed a Memorandum of Understanding in Doha to promote women's advancement and health. The partnership aims to share expertise, create opportunities, and support women in business, healthcare, and the broader community.
- Qatar Red Crescent Society (QRCS)minorQatar Fund for Development funded a seven-day medical convoy in Guyana led by Qatar Red Crescent Society, involving medical teams from Hamad Medical Corporation and Sidra Medicine to perform complex surgeries and consultations. Sidra Medicine contributed medical professionals for the humanitarian mission.
- ScaleReadycoreScaleReady awarded a $100,000 G-Rex Grant to Sidra Medicine for developing a G-Rex centric CAR-T cell therapy platform for pediatric oncology. The grant enables development, validation, and implementation of GMP-compliant semi-automated G-Rex manufacturing system for scalable and cost-effective CAR-T therapy production. ScaleReady collaborated with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady on this grant.
- Middle East Fertility Society (MEFS)minorSidra Medicine partnered with MEFS for its 31st Annual Scientific Meeting on Fertility Care. The strategic partnership supports knowledge exchange and collaboration in reproductive medicine across the Middle East region.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Sidra Medicine competitors and assessment
Company assessmentBroad incumbents
- King Faisal Specialist Hospital and Research Centre: Saudi Arabia's flagship specialty and academic medical center with deep pediatric, oncology, and research programs. Closest GCC analog to Sidra's combined clinical-research-academic model at a larger national scale.
- Cleveland Clinic Abu Dhabi: US-branded academic medical center in the UAE offering advanced specialty care across multiple disciplines. Comparable to Sidra as a regionally leading tertiary hospital with international affiliations and research ambitions.
- Boston Children's Hospital: Global benchmark pediatric academic medical center. Comparable to Sidra in combining subspecialty pediatric care, genomics/precision medicine, and translational research; serves as the model for many of Sidra's recruitment and capability choices.
- Great Ormond Street Hospital for Children (GOSH): UK-based pediatric specialty hospital renowned for complex care, rare diseases, and research. Directly comparable in mission, clinical complexity, and international patient mix.
- The Hospital for Sick Children (SickKids): Toronto pediatric academic medical center with leading precision medicine and genomics programs. Comparable to Sidra on pediatric specialty depth and integration of research with clinical care.
- Children's National Hospital: Washington DC pediatric academic center; Sidra's mental health leadership previously worked there. Comparable on pediatric specialty breadth, mental health, and research-driven care models.
- Mayo Clinic: US-based global academic medical system. Comparable to Sidra on precision medicine, integrated diagnostics, and complex specialty care, though at vastly greater scale and geographic reach.
Direct peers
- Hamad Medical Corporation: Qatar's largest public healthcare system and Sidra's primary domestic counterpart. Both operate as major hospital systems in Doha serving overlapping patient populations, with HMC handling adult and broader services while Sidra focuses on women, children, and research.
Regional players
- Saudi German Hospital Group: Large private hospital group across the Middle East. Comparable as a regional multi-specialty provider competing for the same MENA patient flows that Sidra targets via its global patient services.
- Mediclinic Middle East: Major private hospital operator in the UAE and broader MENA. Comparable as a regionally scaled private hospital chain competing for cross-border specialty patients, though with a broader adult focus than Sidra's pediatric/women's niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Sidra Medicine social profiles
Digital presenceSidra Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sidra Medicine leadership team
Management profileNumber of profiles
Profiles9 records
Sidra Medicine funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sidra Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sidra Medicine
What does Sidra Medicine do?
Sidra Medicine provides specialized clinical care for women, children, and young people through three service divisions: Children & Young People's Services (pediatric orthopedics, mental health, rehabilitation, autism services, obesity care), Women's Services (reproductive medicine and IVF, obstetrics, gynecology, menopause), and Adult Services. The institution complements direct patient care with research programs (precision medicine, genomics, Pediatric Biobank, microbiome analysis, CAR-T cell therapy development) and medical education offerings including observerships and fellowships.
Is Sidra Medicine a public or private company?
Sidra Medicine is a private company. It is classified as state government owned and is currently operating.
When was Sidra Medicine founded?
Sidra Medicine was founded in 2016. It employs 1,001 to 5,000 people.
Where is Sidra Medicine based?
Sidra Medicine is headquartered in Doha, Qatar, in the Middle East region.
How does Sidra Medicine make money?
Five revenue lines are on record. Patient Care Services are the primary driver. The others are insurance Billing, medical Education Programs, research Grants and Partnerships and microbiome Service.
Who are Sidra Medicine's main competitors?
Broad incumbents on record are King Faisal Specialist Hospital and Research Centre, Cleveland Clinic Abu Dhabi, Boston Children's Hospital, Great Ormond Street Hospital for Children (GOSH), The Hospital for Sick Children (SickKids), Children's National Hospital and Mayo Clinic. Hamad Medical Corporation is listed as a direct peer. Regional players are Saudi German Hospital Group and Mediclinic Middle East.
Does Sidra Medicine have an API?
No public API is recorded for Sidra Medicine.
What industry is Sidra Medicine in?
Sidra Medicine's product category is Academic Medical Center / Specialty Pediatric and Women's Healthcare. Its primary akta.pro industry code is HLAFAJAF, Pediatrics & Adolescent Medicine Practices. Its NAICS code is 622110 and its SIC code is 8060.